Drug Profile
Torudokimab - Zura Bio
Alternative Names: IL-33 antibody - Zura Bio; LY-3375880; ZB-880Latest Information Update: 12 Apr 2024
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Developer Eli Lilly and Company; Zura Bio
- Class Anti-inflammatories; Antiasthmatics; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Interleukin-33 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Asthma
- Discontinued Atopic dermatitis